Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$96.41 - $126.61 $1,253 - $1,645
13 New
13 $1,000
Q3 2022

Oct 21, 2022

SELL
$118.07 - $194.18 $2,361 - $3,883
-20 Reduced 22.22%
70 $8,000
Q2 2022

Jul 28, 2022

BUY
$117.13 - $176.59 $2,342 - $3,531
20 Added 28.57%
90 $13,000
Q1 2022

Apr 29, 2022

SELL
$126.46 - $235.05 $175,526 - $326,249
-1,388 Reduced 95.2%
70 $12,000
Q4 2021

Jan 19, 2022

BUY
$225.82 - $368.51 $90,328 - $147,404
400 Added 37.81%
1,458 $370,000
Q3 2021

Nov 01, 2021

BUY
$221.9 - $484.47 $133,140 - $290,682
600 Added 131.0%
1,058 $407,000
Q1 2021

Apr 26, 2021

BUY
$109.18 - $185.98 $50,004 - $85,178
458 New
458 $60,000
Q3 2020

Oct 30, 2020

SELL
$54.34 - $94.85 $120,960 - $211,136
-2,226 Closed
0 $0
Q2 2020

Jul 10, 2020

BUY
$29.67 - $80.0 $66,045 - $178,080
2,226 New
2,226 $143,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Whittier Trust CO Portfolio

Follow Whittier Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO with notifications on news.